U01CA225784
Cooperative Agreement
Overview
Grant Description
Heparan sulfate in prostate cancer.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Tampa,
Florida
336134808
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 03/31/23 to 03/31/25 and the total obligations have increased 330% from $601,970 to $2,588,098.
University Of South Florida was awarded
Heparan Sulfate in Prostate Cancer
Cooperative Agreement U01CA225784
worth $2,588,098
from National Cancer Institute in April 2018 with work to be completed primarily in Tampa Florida United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.396 Cancer Biology Research.
The Cooperative Agreement was awarded through grant opportunity Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01).
Status
(Complete)
Last Modified 6/5/24
Period of Performance
4/13/18
Start Date
3/31/25
End Date
Funding Split
$2.6M
Federal Obligation
$0.0
Non-Federal Obligation
$2.6M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01CA225784
Transaction History
Modifications to U01CA225784
Additional Detail
Award ID FAIN
U01CA225784
SAI Number
U01CA225784-1941666416
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
NKAZLXLL7Z91
Awardee CAGE
1F202
Performance District
FL-15
Senators
Marco Rubio
Rick Scott
Rick Scott
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,751,720 | 100% |
Modified: 6/5/24